Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy

Hematologic dysfunction and myeloid neoplasm risk in patients treated with lutetium-177 prostate specific antigen membrane therapy

Not available.

Saved in:
Bibliographic Details
Main Authors: Yael Kusne, Osama M. Mosalem, Jaxon Quillen, Skye Buckner-Petty, Miguel Muniz, Oliver Sartor, Geoffrey B. Johnson, Daniel S. Childs, Mrinal M. Patnaik
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-04-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/12006
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items